share_log

HC Wainwright & Co. Reiterates Buy on Cytokinetics, Maintains $90 Price Target

HC Wainwright & Co. Reiterates Buy on Cytokinetics, Maintains $90 Price Target

HC Wainwright & Co. 重申对Cytokinetics的买入评级,维持90美元的目标价。
Benzinga ·  06/17 10:55

HC Wainwright & Co. analyst Joseph Pantginis reiterates Cytokinetics (NASDAQ:CYTK) with a Buy and maintains $90 price target.

HC Wainwright & Co.分析师Joseph Pantginis重申CYTK买入评级并维持90美元的目标价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发